Paul Tudor Jones's RPRX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 924,819 shares of Royalty Pharma plc (RPRX) worth $35.74 M, representing 0.07% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in RPRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 296,452 shares. Largest reduction occurred in Q4 2023, reducing 138,083 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Royalty Pharma plc (RPRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Royalty Pharma plc (RPRX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +60,984 | Add 7.06% | 924,819 | $38.64 |
| Q3 2025 | +221,099 | Add 34.40% | 863,835 | $35.28 |
| Q2 2025 | -85,000 | Reduce 11.68% | 642,736 | $36.03 |
| Q1 2025 | -7,291 | Reduce 0.99% | 727,736 | $31.13 |
| Q4 2024 | +226,274 | Add 44.48% | 735,027 | $25.51 |
| Q3 2024 | +196,253 | Add 62.80% | 508,753 | $28.29 |
| Q2 2024 | +296,452 | Add 1847.28% | 312,500 | $26.37 |
| Q1 2024 | -54,742 | Reduce 77.33% | 16,048 | $30.37 |
| Q4 2023 | -138,083 | Reduce 66.11% | 70,790 | $28.09 |
| Q3 2023 | +147,933 | Add 242.75% | 208,873 | $27.14 |
| Q2 2023 | +60,940 | New Buy | 60,940 | $30.74 |
Paul Tudor Jones's Royalty Pharma plc Investment FAQs
Paul Tudor Jones first purchased Royalty Pharma plc (RPRX) in Q2 2023, acquiring 60,940 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Royalty Pharma plc (RPRX) for 11 quarters since Q2 2023.
Paul Tudor Jones's largest addition to Royalty Pharma plc (RPRX) was in Q2 2024, adding 312,500 shares worth $8.24 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 924,819 shares of Royalty Pharma plc (RPRX), valued at approximately $35.74 M.
As of the Q4 2025 filing, Royalty Pharma plc (RPRX) represents approximately 0.07% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Royalty Pharma plc (RPRX) was 924,819 shares, as reported at the end of Q4 2025.